![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Address
GeneChem Management Inc
1001 De Maisonneuve Boulevard West
Suite 920
Montreal QC H3A 3C8
Canada
Phone
Website
Recent investment activity
KANDO id: 3968
Corporate information
Registration country
Company type
Venture capital firm targeting companies in the genomics industryFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| GeneChem Technologies Venture Fund LP | 1997 | CAD | 100,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 9 of 9| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Argos Therapeutics Inc | Series C | ||||
|
|
Argos Therapeutics Inc | Series B | ||||
|
|
Avalon Pharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. | N/A | |||
|
|
IDUN Pharmaceuticals Inc | N/A | ||||
|
|
Ocera Therapeutics Inc | Development of drugs to treat gastrointestinal diseases | N/A | |||
|
|
Scion Pharmaceuticals Inc | N/A | ||||
|
|
Xanthus Pharmaceuticals Inc | N/A | ||||
|
|
Biovex Inc (Biovex Group Inc) | Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. | N/A | |||
|
|
Biovex Inc (Biovex Group Inc) | Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. | Series E |